Finance

Lists
Why is MRK up 3,80%?
Dive Deeper
MRK:NYSE
Merck & Co Inc
147,37 USD
+3,80%
(+5,39) 1D
148,50 USD
+0,77% (+1,13)
After hours
Closed: 14-окт., 16:03:33 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MRK...
Open
143,10 USD
High
148,16 USD
Low
142,66 USD
Mkt. cap
363,59 млд
Avg. vol.
9,33 млн
Volume
0,00
Dividend
2,31%
Quarterly dividend
0,85 USD
Ex-dividend date
2026-ж., 15-сен.
P/E ratio
117,71
52-wk high
156,92 USD
52-wk low
82,01 USD
EPS
1,25 USD
Beta
0,21
Shares outstanding
2,47 млд
No. of employees
74 миң
Open
143,10 USD
High
148,16 USD
Low
142,66 USD
Mkt. cap
363,59 млд
Avg. vol.
9,33 млн
Volume
0,00
Dividend
2,31%
Quarterly dividend
0,85 USD
Ex-dividend date
2026-ж., 15-сен.
P/E ratio
117,71
52-wk high
156,92 USD
52-wk low
82,01 USD
EPS
1,25 USD
Beta
0,21
Shares outstanding
2,47 млд
No. of employees
74 миң
News stories
From web sources and news partners
Profile
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue. The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products. The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000. In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia
About Merck & Co Inc
CEORobert M Davis
Employees74 миң
Founded1891-ж., 1-янв.
Headquarters-
SectorPharmaceutical industry
Websitemerck.com
Analyst ratings
Based on 21 analysts giving stock ratings to MRK in the past 3 months
Buy
Buy
15
Hold
6
Sell
0
12-month forecast
Based on 21 Wall Street analysts offering 12 month price targets for MRK in the last 3 months.
Highest
Current 147,37 USD
180,00 USD (+22,14%)
Average
160,24 USD (+8,73%)
Lowest
105,00 USD (-28,75%)
Analyst
Recommendation
Action
Price target
Projected
Date
Evan Seigerman
BMO Capital
Buy
Maintained
170,00 USD
+15,4%
10/12/2026
Carter Gould
Cantor Fitzgerald
Hold
Maintained
145,00 USD
-1,6%
10/11/2026
Daina Graybosch
Leerink Partners
Buy
Maintained
161,00 USD
+9,2%
10/12/2026
Trung Huynh
RBC Capital
Hold
Reiterated
145,00 USD
-1,6%
10/12/2026
Geoff Meacham
Citi
Hold
Maintained
145,00 USD
-1,6%
10/13/2026
Emily Field
Barclays
Buy
Maintained
150,00 USD
+1,8%
10/12/2026
Michael Yee
UBS
Buy
Maintained
175,00 USD
+18,7%
10/09/2026
Jason Gerberry
Bank of America Securities
Buy
Maintained
163,00 USD
+10,6%
10/09/2026
Terence Flynn
Morgan Stanley
Buy
Maintained
177,00 USD
+20,1%
10/07/2026
Chris Schott
J.P. Morgan
Buy
Maintained
165,00 USD
+12%
10/05/2026
Asad Haider
Goldman Sachs
Buy
Maintained
160,00 USD
+8,6%
09/30/2026
Louise Chen
Scotiabank
Buy
Maintained
180,00 USD
+22,1%
09/29/2026
Steve Scala
TD Cowen
Hold
Maintained
155,00 USD
+5,2%
09/22/2026
Nico Chen
DBS
Buy
Maintained
180,00 USD
+22,1%
09/11/2026
Rajesh Kumar
HSBC
Buy
Maintained
172,00 USD
+16,7%
09/10/2026
Vamil Divan
Guggenheim
Buy
Reiterated
170,00 USD
+15,4%
09/08/2026
Courtney Breen
Bernstein
Hold
Maintained
105,00 USD
-28,8%
09/07/2026
Mohit Bansal
Wells Fargo
Buy
Reiterated
170,00 USD
+15,4%
09/04/2026
Jasper Hellweg
Argus Research
Buy
Reiterated
170,00 USD
+15,4%
08/24/2026
Alexandria Hammond
Wolfe Research
Buy
Maintained
180,00 USD
+22,1%
08/25/2026
Luisa Hector
Berenberg Bank
Hold
Maintained
127,00 USD
-13,8%
08/05/2026
Unknown Analyst
Jefferies
Buy
Maintained
138,00 USD
-6,4%
05/19/2026
Unknown Analyst
Argus Research
Buy
Reiterated
130,00 USD
-11,8%
05/08/2026
Hans Engel
Erste Group
Hold
Maintained
-
-
05/05/2026
Natalya Davies
Rothschild & Co Redburn
Buy
Maintained
179,00 USD
+21,5%
04/17/2026
James Shin
Deutsche Bank
Buy
Upgraded
150,00 USD
+1,8%
02/13/2026
Last report
2026-ж., 4-авг.
Fiscal period
Q2 2026
-0,13 USD / -0,26 USD
+49,43%beat
Revenue / Est. (USD)
16,61 млд / 16,37 млд
+1,46%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
17,28 млд
16,40 млд
16,29 млд
16,61 млд
Cost of goods sold
3,74 млд
4,30 млд
3,88 млд
4,13 млд
Cost of revenue
3,74 млд
4,30 млд
3,88 млд
4,13 млд
Research and development expenses
4,00 млд
4,00 млд
3,56 млд
9,74 млд
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,48 млд
2,73 млд
2,57 млд
2,78 млд
Operating expense
6,48 млд
6,73 млд
6,12 млд
12,52 млд
Total operating expenses
10,23 млд
11,02 млд
10,00 млд
16,65 млд
Operating income
7,05 млд
5,38 млд
6,29 млд
-40,00 млн
Other non operating income
-
41,00 млн
42,00 млн
59,00 млн
EBT including unusual items
6,74 млд
3,42 млд
-3,53 млд
-683,00 млн
EBT excluding unusual items
6,76 млд
4,98 млд
5,85 млд
-508,00 млн
Income tax expense
958,00 млн
458,00 млн
709,00 млн
654,00 млн
Effective tax rate
14,20%
13,39%
-20,06%
-95,75%
Other operating expenses
-
-
-
-
Net income
5,78 млд
2,96 млд
-4,24 млд
-1,34 млд
Net profit margin
33,49%
18,07%
-26,03%
-8,04%
Earnings per share
2,58
2,04
-1,28
-0,13
Interest and investment income
96,00 млн
69,00 млн
35,00 млн
35,00 млн
Interest expense
-327,00 млн
-411,00 млн
-479,00 млн
-525,00 млн
Net interest expenses
-231,00 млн
-342,00 млн
-444,00 млн
-490,00 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
8,15 млд
6,79 млд
7,69 млд
1,43 млд
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору